B-type natriuretic peptide as an alternative way of assessing total cardiovascular risk in patients with diabetes mellitus

American Journal of Cardiology

Volumn 96, Issue 7, 2005, Pages 933-934

  Dawson, Adelle ^a   Jeyaseelan, Sanjay ^b   Morris, Andrew D ^c   Struthers, Allan D ^c  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MEASUREMENT; NEW ZEALAND; PRIORITY JOURNAL; SCORING SYSTEM; STROKE;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RISK ASSESSMENT; RISK FACTORS;

EID: 25444525714     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.05.050     Document Type: Article

References (4)

1. EUROASPIRE I AND II Group Clinical reality of coronary prevention guidelines a comparison of EUROASPIRE I and II in nine countries Lancet 357 2001 995 1001
2. L. Hall, R. Jung, G. Leese Controlled trial of effect of documented cardiovascular risk scores on prescribing BMJ 326 2003 251 252
3. T.J. Wang, M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, T. Omland, P.A. Wolf, R.S. Vasan Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
4. M.A. Bhalla, A. Chiang, V.A. Epshteyn, R. Kazanegra, V. Bhalla, P. Clopton, P. Krishnaswamy, L.K. Morrison, A. Chiu, N. Gardetto Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus J Am Coll Cardiol 44 2004 1047 1052